Yıl: 2020 Cilt: 19 Sayı: 2 Sayfa Aralığı: 68 - 73 Metin Dili: İngilizce DOI: 10.4274/uob.galenos.2020.1426 İndeks Tarihi: 09-10-2020

Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features

Öz:
Objective: Nowadays, with the use of advanced imaging methods, the incidence of renal cell carcinomas (RCCs) has increased steadily and they have become recognizable at early stage. Morphologically and immunophenotypically, RCCs are divided into many different types and are divided into three main subtypes. Each type has differences in terms of genetics, biology, and behavior. The objectives of this study is to investigate the histopathological features of tumor specimens of patients operated with diagnosis of RCC.Materials and Methods: The pathology specimens and reports of 77 patients with RCC who underwent radical or partial nephrectomy were reviewed retrospectively. Descriptive and clinical data of the patients were obtained. The size, lateralization, focality, histopathological type, Fuhrman nuclear grading system (NGS), sarcomatoid change, renal sinus and vein invasions, perirenal fat tissue invasion, hilar fatty tissue invasion, ureter surgical margin, and primary tumor stage of RCC were determined.Results: According to the histopathologic type, 77.9% of the patients had clear cell RCC, 10.4% chromophobe RCC, 9.1% papillary RCC, and 2.6% multilocular RCC. The Fuhrman NGS values were 5.2% for grade 1, 61% for grade 2, 26% for grade 3, and 7.8% for grade 4. There were sarcomatoid features in only 7.8% of the patients. There were 6 patients (7.8%) with renal sinus invasion, 3 patients (3.9%) with renal vein invasion, 8 patients (10.4%) with perirenal adipose tissue invasion, 2 patients (2.6%) with hilar fat tissue invasion, and 2 patients (2.6%) with tumors at the ureter surgical margin. Pathological changes were significantly differentiated according to gender except for the primary tumor stage.Conclusion: RCCs are divided into many different types and each type has differences in terms of genetics, biology, and behavior. Due to this, the pathologist must differentiate cell types routinely by morphology and immunohistochemical markers as well as by cytogenetic and molecular genetic analysis particularly when the cell type is equivocal.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Campbell SC, Lane BR. Malignant renal tumors in Campbell-Walsh Urology. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Philadelphia:Saunders-Elsevier; 2011. pp.1413-1474.
  • 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.
  • 3. Cairns P. Renal cell carcinoma. Cancer Biomark 2010;9:461-473.
  • 4. Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol 2019;75:74-84.
  • 5. Delahunt B, Cheville JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013;37:1490-1504.
  • 6. CAP. College of American Pathologists. Cancer protocol templates 2017. Available from: https://www.cap.org/protocols-andguidelines/cancer-reporting-tools/cancer-protocol-templates#!@@?_ afrLoop=50758928733115&_adf.ctrl-state=3jlqfweu7_4 (Acces date: August 08, 2019).
  • 7. Amin MB, Edge SB. In: Cancer AJCo, editor. AJCC cancer staging manual. Chicago: Springer; 2017.
  • 8. Graham TM, Stevens TM, Gordetsky JB. Pathology of renal tumors. In: Gorin M., Allaf M. (eds) Diagnosis and surgical management of renal tumors. Springer, Cham 2019.
  • 9. Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers 2017;3:17009.
  • 10. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours. Eur Urol 2016;70:93-105.
  • 11. Escudier B, Porta C, Schmidinger M, et al. ESMO Guidelines Committee. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):58-68.
  • 12. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663.
  • 13. Ficarra V, Righetti R, Martignoni G, et al. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 2001;67:130-134.
  • 14. Rioux-Leclercq N, Karakiewicz PI, Trinh QD, et al. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 2007;109:868-874.
  • 15. Sun M, Lughezzani G, Jeldres C, et al. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 2009;56:775-781.
  • 16. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder, and related urinary structures. Atlas of tumor pathology. 4th ed. Fascicle 1. AFIP. Washington; 2004.
  • 17. Hong SK, Jeong CW, Park JH, et al. Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma. BJU Int 2011;107:409-415.
  • 18. Turk A, Aslan H, Balaban M, Demirkol MK, Tarhan F. Clinical and histopathological features of the renal cell carcinomas of kidney (Turkish). J Kartal TR 2014;25:124-126.
  • 19. Shuch B, Vourganti S, Ricketts CJ, et al. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol 2014;32:431-437. 20. Moch H. An overview of renal cell cancer: pathology and genetics. Semin Cancer Biol 2013;23:3-9.
  • 21. Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 2009;22:24-36.
  • 22. Medeiros LJ, Jones EC, Aizawa S, Aldape HC, Cheville JC, Goldstein NS, et al. Grading of renal cell carcinoma: Workgroup No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:990-991.
  • 23. Engers R. Reproducibility and reliability of tumor grading in urological neoplasms. World J Urol 2007;25:595-605.
  • 24. Motzer RJ, Jonasch E, Agarwal N, et al. (National comprehensive cancer network). Kidney cancer, version 3.2015. J Natl Compr Canc Netw 2015;13:151-159.
  • 25. Swami U, Nussenzveig RH, Haaland B, Agarwal N. Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement. Ann Transl Med 2019;7:S18.
  • 26. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002;167:57-60.
APA gürsoy d, Secinti I, HAKVERDI S, GORUR S (2020). Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. , 68 - 73. 10.4274/uob.galenos.2020.1426
Chicago gürsoy didar,Secinti Ilke Evrim,HAKVERDI SIBEL,GORUR Sadik Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. (2020): 68 - 73. 10.4274/uob.galenos.2020.1426
MLA gürsoy didar,Secinti Ilke Evrim,HAKVERDI SIBEL,GORUR Sadik Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. , 2020, ss.68 - 73. 10.4274/uob.galenos.2020.1426
AMA gürsoy d,Secinti I,HAKVERDI S,GORUR S Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. . 2020; 68 - 73. 10.4274/uob.galenos.2020.1426
Vancouver gürsoy d,Secinti I,HAKVERDI S,GORUR S Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. . 2020; 68 - 73. 10.4274/uob.galenos.2020.1426
IEEE gürsoy d,Secinti I,HAKVERDI S,GORUR S "Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features." , ss.68 - 73, 2020. 10.4274/uob.galenos.2020.1426
ISNAD gürsoy, didar vd. "Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features". (2020), 68-73. https://doi.org/10.4274/uob.galenos.2020.1426
APA gürsoy d, Secinti I, HAKVERDI S, GORUR S (2020). Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. Üroonkoloji Bülteni, 19(2), 68 - 73. 10.4274/uob.galenos.2020.1426
Chicago gürsoy didar,Secinti Ilke Evrim,HAKVERDI SIBEL,GORUR Sadik Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. Üroonkoloji Bülteni 19, no.2 (2020): 68 - 73. 10.4274/uob.galenos.2020.1426
MLA gürsoy didar,Secinti Ilke Evrim,HAKVERDI SIBEL,GORUR Sadik Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. Üroonkoloji Bülteni, vol.19, no.2, 2020, ss.68 - 73. 10.4274/uob.galenos.2020.1426
AMA gürsoy d,Secinti I,HAKVERDI S,GORUR S Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. Üroonkoloji Bülteni. 2020; 19(2): 68 - 73. 10.4274/uob.galenos.2020.1426
Vancouver gürsoy d,Secinti I,HAKVERDI S,GORUR S Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features. Üroonkoloji Bülteni. 2020; 19(2): 68 - 73. 10.4274/uob.galenos.2020.1426
IEEE gürsoy d,Secinti I,HAKVERDI S,GORUR S "Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features." Üroonkoloji Bülteni, 19, ss.68 - 73, 2020. 10.4274/uob.galenos.2020.1426
ISNAD gürsoy, didar vd. "Renal Cell Carcinoma: Epidemiological Profile and Histopathological Features". Üroonkoloji Bülteni 19/2 (2020), 68-73. https://doi.org/10.4274/uob.galenos.2020.1426